1006891-33-3Relevant articles and documents
Tetrahydropyran carboxylic acid derivative and synthesis method thereof
-
, (2020/12/06)
The invention belongs to the technical field of organic synthesis, and relates to (3S,4S)-3-(((9H-fluorene-9-yl)methoxy)carbonyl)-tetrahydro-2H-pyran-4-carboxylic acid and a synthesis method thereof.The provided synthetic method comprises the following steps: taking 3-butene-1-ol and 2-bromo-1,1-diethoxyethane as raw materials, and carrying out nine steps: substitution, substitution, cyclization,catalytic hydrogenation, Boc feeding, oxidation, chiral resolution, Boc removal and substitution reaction to prepare (3S, 4S)-3-((((9H-fluorene-9-yl) methoxy) carbonyl)-tetrahydro-2H-pyran-4-carboxylic acid. The synthetic route is simple, the cost is low, the efficiency is high, and the synthesized product can be used as a new medical intermediate.
HETEROCYCLIC COMPOUND
-
, (2017/02/09)
The present invention provide a heterocyclic compound having a HDAC inhibitory action, and useful for the treatment of autoimmune diseases and/or inflammatory diseases, graft versus host disease, cancers, central nervous diseases including neurodegenerative diseases, Charcot-Marie-Tooth disease and the like, and a pharmaceutical composition comprising the compound. The present invention relates to a compound represented by the formula (I): wherein each symbol is as defined in the specification, or a salt thereof.
Cyclic beta-amino acid derivatives as factor Xa inhibitors
-
Page/Page column 53, (2010/10/20)
The present application describes cyclic β-amino acid derivatives or pharmaceutically acceptable salt forms thereof, wherein the central core is a non-aromatic carbocycle or heterocycle. Compounds of the present invention are useful as inhibitors of trypsin-like serine proteases, specifically factor Xa.